التقييم

• أ.د.عمرو عادل منسى

  نساء و توليد

  Hydroxychloroquine has been studied as a potential treatment for neuroimmune disorders such as multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD). hydroxychloroquine 200 mg Its immunomodulatory effects may help reduce inflammation and demyelination in the central nervous system, leading to improved clinical outcomes in some patients. However, evidence supporting the use of hydroxychloroquine in these conditions is limited, and further research is needed to determine its efficacy and safety.

  20 مارس 2024